Skip to main content
. 2013 Oct 11;8(10):e76455. doi: 10.1371/journal.pone.0076455

Figure 5. Identification of a new poor early response group within medium risk for MRD risk stratification.

Figure 5

Kaplan Meier survival curves are shown for A) the 150 medium risk precursor B-ALL patients split into poor early responders (PER) defined as MRD day 15≥1×10−2 AND day 33 MRD≥5×10−5 and good molecular responders with MRD day 15<1×10−2 OR day 33 MRD<5×10−5 B) The original stratification of whole cohort of 253 patients into standard risk (SR), medium risk patients (MR) and high risk (HR) groups according to ANZCHOG ALL8 protocol criteria and C) the whole cohort stratified according to the new criteria with the PER subset of medium risk B-ALL patients defined separately. The number of patients and 5 year relapse-free survival percentage are given for each subgroup.